Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James M Mathew

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Plos One|May 29, 2019
Mechanistic analyses in kidney transplant recipients prospectively randomized to two steroid free regimen-Low dose Tacrolimus with Everolimus versus standard dose Tacrolimus with Mycophenolate MofetilOpas Traitanon, James M Mathew, Aneesha Shetty, et al.
Transplant Immunology|September 12, 2003
Immune responses and their regulation by donor bone marrow cells in clinical organ transplantationJames M Mathew, Rolando O Garcia-Morales, Manuel Carreno, et al.
Human Immunology|September 18, 2007
Inhibition of NF-kappa B during human dendritic cell differentiation generates anergy and regulatory T-cell activity for one but not two human leukocyte antigen DR mismatchesAna Hernandez, Melissa Burger, Bonnie B Blomberg, et al.
Clinical Transplants|August 7, 2014
HLA identical non-chimeric and HLA disparate chimeric renal transplant toleranceJoseph R Leventhal, James M Mathew, Suzanne Ildstad, et al.
Kidney International|October 30, 2014
Cellular and molecular immune profiles in renal transplant recipients after conversion from tacrolimus to sirolimusLorenzo Gallon, Opas Traitanon, Nedjema Sustento-Reodica, et al.
Hepatology (Baltimore, Md.)|November 14, 2019
Immunosuppression Withdrawal in Liver Transplant Recipients on SirolimusJosh Levitsky, Bryna E Burrell, Sai Kanaparthi, et al.
Hepatology (Baltimore, Md.)|January 12, 2012
Systemic immunoregulatory and proteogenomic effects of tacrolimus to sirolimus conversion in liver transplant recipientsJosh Levitsky, James M Mathew, Michael Abecassis, et al.
Transplantation|August 27, 2005
A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoringGaetano Ciancio, George W Burke, Jeffrey J Gaynor, et al.
Scientific Reports|November 2, 2019
Author Correction: Varying levels of X chromosome coalescence in female somatic cells alters the balance of X-linked dosage compensation and is implicated in female-dominant systemic lupus erythematosusAgnieszka I Laskowski, Daniel S Neems, Kyle Laster, et al.
Scientific Reports|May 31, 2019
Varying levels of X chromosome coalescence in female somatic cells alters the balance of X-linked dosage compensation and is implicated in female-dominant systemic lupus erythematosusAgnieszka I Laskowski, Daniel S Neems, Kyle Laster, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Plos One|May 29, 2019
Mechanistic analyses in kidney transplant recipients prospectively randomized to two steroid free regimen-Low dose Tacrolimus with Everolimus versus standard dose Tacrolimus with Mycophenolate MofetilOpas Traitanon, James M Mathew, Aneesha Shetty, et al.
Transplant Immunology|September 12, 2003
Immune responses and their regulation by donor bone marrow cells in clinical organ transplantationJames M Mathew, Rolando O Garcia-Morales, Manuel Carreno, et al.
Human Immunology|September 18, 2007
Inhibition of NF-kappa B during human dendritic cell differentiation generates anergy and regulatory T-cell activity for one but not two human leukocyte antigen DR mismatchesAna Hernandez, Melissa Burger, Bonnie B Blomberg, et al.
Clinical Transplants|August 7, 2014
HLA identical non-chimeric and HLA disparate chimeric renal transplant toleranceJoseph R Leventhal, James M Mathew, Suzanne Ildstad, et al.
Kidney International|October 30, 2014
Cellular and molecular immune profiles in renal transplant recipients after conversion from tacrolimus to sirolimusLorenzo Gallon, Opas Traitanon, Nedjema Sustento-Reodica, et al.
Hepatology (Baltimore, Md.)|November 14, 2019
Immunosuppression Withdrawal in Liver Transplant Recipients on SirolimusJosh Levitsky, Bryna E Burrell, Sai Kanaparthi, et al.
Hepatology (Baltimore, Md.)|January 12, 2012
Systemic immunoregulatory and proteogenomic effects of tacrolimus to sirolimus conversion in liver transplant recipientsJosh Levitsky, James M Mathew, Michael Abecassis, et al.
Transplantation|August 27, 2005
A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoringGaetano Ciancio, George W Burke, Jeffrey J Gaynor, et al.
Scientific Reports|November 2, 2019
Author Correction: Varying levels of X chromosome coalescence in female somatic cells alters the balance of X-linked dosage compensation and is implicated in female-dominant systemic lupus erythematosusAgnieszka I Laskowski, Daniel S Neems, Kyle Laster, et al.
Scientific Reports|May 31, 2019
Varying levels of X chromosome coalescence in female somatic cells alters the balance of X-linked dosage compensation and is implicated in female-dominant systemic lupus erythematosusAgnieszka I Laskowski, Daniel S Neems, Kyle Laster, et al.
Pageof 6